Efficacy and safety of postoperative adjuvant chemotherapy in colorectal cancer patients with sarcopenia: single-center retrospective observational study

Postoperative adjuvant chemotherapy for colorectal cancer in sarcopenic patients - Postoperative adjuvant chemotherapy for colorectal cancer in sarcopenic patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000052063

Enrollment

320

Registered

2023-09-01

Start date

2023-08-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Patients who underwent resection surgery for colorectal cancer (adenocarcinoma of the colon and rectum) between January 1, 2015 and December 31, 2022 at the Department of Gastroenterology and General Surgery, Shimane University Hospital. 2.Patients who are eligible for postoperative adjuvant chemotherapy according to the colorectal cancer treatment guidelines

Exclusion criteria

Exclusion criteria: 1.Patients without preoperative CT scan 2.Patients undergoing postoperative adjuvant chemotherapy at another hospital 3.Patients who have opted out and have been refused access to medical information by research subjects or their familiy 4.Patients with multiple cancers

Design outcomes

Primary

Measure	Time frame
Adverse event rate of postoperative adjuvant chemotherapy Postoperative chemotherapy completion rate Recurrence-free survival Overall survival	—

Countries

Japan

Contacts

Public ContactTakahito Taniura

Shimane University Faculty of Medicine Department of Digestive and General Surgery

taniura@med.shimane-u.ac.jp0853202232

Outcome results